Arrowgrass Capital Partners (US)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-159,612
Closed -$8.57M 360
2017
Q4
$8.57M Buy
159,612
+98,114
+160% +$5.44M 0.08% 245
2017
Q3
$3.76M Sell
61,498
-133,562
-68% -$8.1M 0.03% 393
2017
Q2
$11.9M Buy
195,060
+119,715
+159% +$7.29M 0.09% 275
2017
Q1
$4.57M Sell
75,345
-196,983
-72% -$12M 0.05% 338
2016
Q4
$15.3M Buy
272,328
+272,253
+363,004% +$15.9M 0.17% 119
2016
Q3
$4K Hold
75
﹤0.01% 445
2016
Q2
$4K Hold
75
﹤0.01% 418
2016
Q1
$4K Hold
75
﹤0.01% 392
2015
Q4
$4K Hold
75
﹤0.01% 395
2015
Q3
$4K Sell
75
-270,315
-100% -$14.4M ﹤0.01% 450
2015
Q2
$14.7M Buy
270,390
+249,210
+1,177% +$14M 0.22% 90
2015
Q1
$1.16M Buy
21,180
+17,970
+560% +$1.02M 0.02% 319
2014
Q4
$174K Buy
+3,210
New +$179K ﹤0.01% 391
2014
Q3
Sell
-80,034
Closed -$4.42M 340
2014
Q2
$4.42M Sell
80,034
-86,920
-52% -$4.74M 0.13% 99
2014
Q1
$9.04M Buy
166,954
+40,672
+32% +$2.11M 0.36% 63
2013
Q4
$6.03M Buy
+126,282
New +$5.77M 0.28% 70

Other funds holding MRK

Arrowgrass Capital Partners (US)'s MRK Position: Q1 2018 in Review

Arrowgrass Capital Partners (US) sold out of Merck (MRK) in Q1 2018, closing a stake of 159,612 shares — an estimated $8.57M sold.

Arrowgrass Capital Partners (US) first reported a position in MRK in Q4 2013 and held it in 16 quarters. The position peaked at $15.3M in Q4 2016. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • Arrowgrass Capital Partners (US) reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 159,612 Merck shares in Q1 2018, an estimated $8.57M.
  • Arrowgrass Capital Partners (US) first reported a position in Merck in Q4 2013 and held it in 16 quarters.
  • Arrowgrass Capital Partners (US)'s Merck position peaked at $15.3M in Q4 2016.
  • 1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.